About Us | BCI Pharma

About Us

BCI Pharma was set up in March 2013.
The two founders have extensive expertise in discovery and patient treatment.

Dr. Dominique Surleraux was head of research for a pharmaceutical company (J&J) and two biotech companies (Idenix and Tibotec). Dr. Elisabeth Picou had a position in a hospital, treating patients with infectious diseases.


BCI Pharma Missions

Our company is a Contract Research Organisation offering services and innovative products (new chemotypes) to increase the efficacy of drug discovery and ensure strong a intellectual property position and a low attrition rate.

Our kinase platform is based on a new chemotype with excellent phys-chem properties, able to explore a new chemical space and as such very promising for treating CNS, inflammation, cancer and metabolic diseases.